# Effects of Nicotinamide Riboside on the Clinical Outcome of Covid-19 in the Elderly

> **NCT04407390** · PHASE2 · WITHDRAWN · sponsor: **University of Copenhagen**

## Conditions studied

- COVID

## Interventions

- **DIETARY_SUPPLEMENT:** Nicotinamide riboside
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT04407390
- **Lead sponsor:** University of Copenhagen
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-06-01
- **Primary completion:** 2021-05-01
- **Final completion:** 2022-05-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No volunteers where recruited to this study. Other studies were prioritised over this at the time of enrollment.
- **Last updated:** 2022-09-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04407390

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04407390, "Effects of Nicotinamide Riboside on the Clinical Outcome of Covid-19 in the Elderly". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04407390. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*